Effects of pioglitazone on the differentiation and inflammation in vitiligo keratinocytes

J Eur Acad Dermatol Venereol. 2024 Jul;38(7):e573-e575. doi: 10.1111/jdv.19754. Epub 2024 Feb 2.

Authors

E Bastonini¹, D Kovacs¹, S Briganti¹, M Ottaviani¹, A D'Arino¹, E Migliano², A Pacifico³, P Iacovelli³, M Picardo⁴

Affiliations

¹ Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.
² Department of Plastic and Reconstructive Surgery, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.
³ Clinical Dermatology, Phototherapy Unit, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.
⁴ Istituto Dermopatico dell'Immacolata (IDI-IRCCS), Rome, Italy.

PMID: 38305589
DOI: 10.1111/jdv.19754

No abstract available

Publication types

Letter

MeSH terms

Cell Differentiation* / drug effects
Cells, Cultured
Humans
Hypoglycemic Agents / pharmacology
Hypoglycemic Agents / therapeutic use
Inflammation / drug therapy
Keratinocytes* / drug effects
Pioglitazone* / pharmacology
Pioglitazone* / therapeutic use
Thiazolidinediones / pharmacology
Thiazolidinediones / therapeutic use
Vitiligo* / drug therapy

Substances

Pioglitazone
Thiazolidinediones
Hypoglycemic Agents

Grants and funding

Ministero della Salute